Pattni, K, Hungerford, D, Adams, S, Buchan, I, Cheyne, C P, García-Fiñana, M, Hall, I, Hughes, D M, Overton, C E, Zhang, X & Sharkey, K J 2022, ' Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2 ', BMC Infectious Diseases, vol. 22, no. 1, 270 . https://doi.org/10.1186/s12879-022-07239-z